Today: 21 May 2026
Why Life360 stock is sliding today as year-end trading hits tech names
31 December 2025
1 min read

Why Life360 stock is sliding today as year-end trading hits tech names

NEW YORK, December 31, 2025, 11:12 ET — Regular session

Life360, Inc. shares were down 4.4% at $63.79 in morning trading, after moving between $63.79 and $67.05. The Nasdaq-listed stock was off $2.94 from Tuesday’s close and had traded about 108,000 shares.

The move comes as investors close the books on the final trading day of 2025, a stretch that often brings thinner liquidity and sharper price swings in smaller growth stocks.

Wall Street’s major indexes were slightly lower and tech stocks extended losses as markets looked ahead to the path of U.S. interest rates into 2026. “The economy showed remarkable strength,” said Adam Turnquist, chief technical strategist at LPL Financial. Reuters

Life360 runs a family safety and location-sharing mobile app and sells Tile tracking devices, with subscriptions as its core revenue engine.

In its most recent results update, Life360 (NASDAQ: LIF, ASX: 360) said third-quarter revenue rose 34% to $124.5 million and monthly active users grew to about 91.6 million, while Paying Circles reached 2.7 million. The company also lifted its full-year revenue outlook to $474 million to $485 million and raised its adjusted EBITDA forecast to $84 million to $88 million, a profit metric that strips out interest, taxes, depreciation and amortization. Life360 also said it agreed to acquire advertising technology firm Nativo for about $120 million in cash and stock.

For investors, the key question is whether advertising and partnership revenue can scale without squeezing margins in the subscription business, where conversion and retention remain the core drivers.

Wall Street is also watching how quickly Life360 can integrate Nativo and turn its location data into a larger, steadier revenue stream.

Life360’s next quarterly report is expected on Feb. 26, according to Zacks’ earnings calendar, putting year-end user trends and 2026 guidance back in focus.

U.S. stock markets are closed on Thursday for New Year’s Day and are scheduled to resume their core trading session on Friday, the NYSE holiday calendar shows.

Stock Market Today

  • Asian Shares Surge as Oil Prices Dip and Nvidia Drives AI Rally
    May 20, 2026, 10:35 PM EDT. Asian shares surged Thursday following a drop in oil prices and easing pressure from the bond market. South Korea's Kospi led gains with a 6.7% jump, boosted by technology stocks including Samsung Electronics and SK Hynix. Taiwan's Taiex and Japan's Nikkei also climbed. Nvidia's strong quarterly results, showing a 200% profit increase and 85% revenue rise driven by AI chip demand, fueled optimism despite a post-earnings dip. U.S. stocks rallied, with the S&P 500 up 1.1%, helped by a fall in the 10-year Treasury yield to 4.57%. Brent crude fell but managed a slight recovery to $105.50 per barrel amid volatile Iran-related supply concerns. The softening yields eased fears of aggressive rate hikes, supporting equities and growth in AI sector investments.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking
Previous Story

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking

XRP price today: Ripple-linked token slips as year-end trading thins — key levels before 2026
Next Story

XRP price today: Ripple-linked token slips as year-end trading thins — key levels before 2026

Go toTop